Cystetic Medicines
Initial Transaction Details
Transaction Date
November 2020
Purpose of Financing
Venture
Stage of Company
Seed/Startup
Structure of Financing
Equity
cystetic Medicines is a clinical-stage biotechnology company pioneering the development of small molecule anion channel molecular prosthetics to restore pulmonary function in people with Cystic Fibrosis. The company was founded in 2020, based on the work of Dr. Martin Burke of the University of Illinois at Urbana-Champaign and Dr. Michael Welsh at the University of Iowa.
Website